Verily

Last updated

Verily Life Sciences LLC
FormerlyGoogle Life Sciences
Type Subsidiary
Industry
FoundedDecember 7, 2015;8 years ago (2015-12-07)
Key people
Stephen Gillett (CEO)
RevenueUS$559 million (2022)
−US$568 million (2022)
Owner Google Inc. (until 2015)
Alphabet Inc. (2015–present)
Number of employees
c.1,100 (2023)
Parent Alphabet Inc.
Subsidiaries Lift Labs
Website verily.com
Footnotes /references
[1]

Verily Life Sciences LLC, [2] also known as Verily (formerly Google Life Sciences), is Alphabet Inc.'s research organization devoted to the study of life sciences. [3] [4] The organization was formerly a division of Google X, until August 10, 2015, when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc. [5] with restructuring completed on October 2, 2015. On December 7, 2015, Google Life Sciences was renamed Verily. [6] [7]

Contents

Early Researchers

At the time of Verily's formation in 2015, the members of the research team that contributed to the founding patent portfolio include: [8]

History

On 9 September 2014, the division acquired Lift Labs, the makers of Liftware. [9]

Verily Life Sciences in January 2019 raised $1 billion in funding.

At the end of 2019, Verily sold its stake in robot-assisted surgery joint venture Verb Surgical to development partner Johnson & Johnson. [10]

In August 2020, Verily announced that it is entering into the insurance market with the launch of Coefficient Insurance Company. The new subsidiary will be backed by Swiss Re Group's commercial insurance unit. [11]

In September 2022, Verily announced longtime CEO Andy Conrad would step down as CEO in January 2023, to be replaced by Stephen Gillett [12] who became CEO on January 3, 2023. [13]

In January 2023, fifteen percent of Verily's workforce was laid off as part of a broader restructuring by parent company, Alphabet. [14] The Information reported in August that Gillett had told employees they would stop relying on Alphabet on "a wide range of corporate services", signaling a potential spin-out as an independent company. [15]

Projects

Discontinued

See also

Related Research Articles

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.

<span class="mw-page-title-main">Apollo Hospitals</span> Indian hospital chain

Apollo Hospitals Enterprise Limited is an Indian multinational healthcare group headquartered in Chennai. It is the largest hospital chain in India, with a network of 71 owned and managed hospitals. Along with the eponymous hospital chain, the company also operates pharmacies, primary care and diagnostic centres, telehealth clinics, and digital healthcare services among others through its subsidiaries.

<span class="mw-page-title-main">Google Health</span> Division of Google

Google Health was a project by Google designed as an attempt to create a repository of health records and data in order to connect doctors, hospitals and pharmacies directly. The project was introduced in 2008 and discontinued in 2012. Google Health was restarted in 2018 but appeared to be discontinued in 2021 and was officially called an "effort" rather than a separate division as of 2022.

<span class="mw-page-title-main">GV (company)</span> Venture capital unit of Alphabet Inc.

GV Management Company, L.L.C. is a venture capital investment arm of Alphabet Inc., founded by Bill Maris, that provides seed, venture, and growth stage funding to technology companies. Founded as Google Ventures in 2010, the firm has operated independently of Google, Alphabet's search and advertising division, since 2015. GV invests in startup companies in a variety of fields ranging from the Internet, software, and hardware to life science, healthcare, artificial intelligence, transportation, cyber security and agriculture. It has helped finance more than 300 companies that include Uber, Nest, Slack, and Flatiron Health.

Stephen Gillett is an American businessman, entrepreneur and technology leader. He is currently the President and chief executive officer at Verily, formerly Google Life Sciences. He was chief executive officer of Chronicle Security, an Alphabet company born out of X, the moonshot factory and founded in 2016. Gillett is also an active adviser at Google Ventures and X.

DexCom, Inc. is a company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) who require insulin injections or pumps diabetes management. It operates internationally with headquarters in San Diego, California, has manufacturing facilities in Mesa, Arizona and Penang, Malaysia, with future manufacturing facilities in Athenry, Ireland.

Dr. Frederic Moll is a medical device developer and entrepreneur, specializing in the field of medical robotics.

<span class="mw-page-title-main">X Development</span> American research and development company

X Development LLC, doing business as X, is an American semi-secret research and development facility and organization founded by Google in January 2010. X has its headquarters about a mile and a half from Alphabet's corporate headquarters, the Googleplex, in Mountain View, California.

Calico Life Sciences LLC is a subsidiary of Alphabet Inc. with a focus on biotechnology. Calico's goal is to increase the understanding of the biology that controls human aging, attempting to to devise interventions that may enable people to lead longer and healthier lives.

Google Contact Lens was a smart contact lens project announced by Google on 16 January 2014. The project aimed to assist people with diabetes by constantly measuring the glucose levels in their tears. The project was being carried out by Verily and as of 2014 was being tested using prototypes. On November 16, 2018, Verily announced it had discontinued the project.

Project Baseline is a broad effort to map human health led by Verily Life Sciences, Alphabet, Inc.'s health sciences division, and was announced in the Wall Street Journal on July 24, 2014. It begins with the ProjectBaseline Study, which will collect phenotypic health data from approximately 10,000 participants over the course of at least four years. The project employs experts from widely varying fields including science, medicine, user experience and design, engineering and patient advocacy. The project is not the first one to aim to collect data on many individuals for medical purposes, but it aims to collect a much larger amount of data covering a broader array of topics than its predecessors. De-identified Project Baseline study data will be available to qualified researchers for exploratory analysis in the future. Qualified external researchers may apply through applications reviewed by the Proposal Review and Publications Committee and Scientific Executive Committee.

<span class="mw-page-title-main">Robert Califf</span> American cardiologist (born 1951)

Robert McKinnon Califf is an American cardiologist who currently serves as the 25th Commissioner of the Food and Drug Administration.

<span class="mw-page-title-main">Alphabet Inc.</span> American multinational technology conglomerate

Alphabet Inc. is an American multinational technology conglomerate holding company headquartered in Mountain View, California. It was created through a restructuring of Google on October 2, 2015, and became the parent company of Google and several former Google subsidiaries. Alphabet is the world's third-largest technology company by revenue and one of the world's most valuable companies. It is considered one of the Big Five American information technology companies, alongside Amazon, Apple, Meta, and Microsoft.

Oscar Health, Inc. is an American health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company focuses on the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems which would make it easier for patients to navigate.

Sidewalk Labs LLC is an urban planning and infrastructure subsidiary of Google. Its stated goal is to improve urban infrastructure through technological solutions, and tackle issues such as cost of living, efficient transportation and energy usage. The company was headed by Daniel L. Doctoroff, former Deputy Mayor of New York City for economic development and former chief executive of Bloomberg L.P. until 2021. Other notable employees include Craig Nevill-Manning, co-founder of Google's New York office and inventor of Froogle, and Rohit Aggarwala, who served as chief policy officer of the company and is now Commissioner of New York City Department of Environmental Protection. It was originally part of Alphabet Inc., Google's parent company, before being absorbed into Google in 2021 following Doctoroff's departure from the company due to a suspected ALS diagnosis.

<span class="mw-page-title-main">Andrew Conrad</span> American geneticist (born 1964)

Andrew J. Conrad is an American geneticist who heads Verily, a life sciences division of Alphabet Inc. As its chief executive officer, Conrad has recruited a multidisciplinary team of chemists, doctors, engineers, behavioral scientists and data scientists to research health and disease.

Galvani Bioelectronics is a Stevenage, United Kingdom-based bioelectronics R&D company.

<span class="mw-page-title-main">Continuous glucose monitor</span> Blood glucose monitoring device

A continuous glucose monitor (CGM) is a device used for monitoring blood glucose on a continual basis instead of monitoring glucose levels periodically by drawing a drop of blood from a finger. CGMs are used by people who treat their diabetes with insulin, for example people with type I diabetes, type II diabetes, or other types of diabetes, such as gestational diabetes.

<span class="mw-page-title-main">Dimitri Azar</span>

Dimitri Azar is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018.

<span class="mw-page-title-main">Moncef Slaoui</span> Moroccan-American-Belgian doctor and researcher

Moncef Mohamed Slaoui is a Moroccan-born Belgian-American researcher who served as the head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021.

References

  1. Tanna, Shivani (August 16, 2023). "Alphabet's Verily plans cost cuts amid pressure on Other Bets unit - WSJ". Reuters.
  2. "Verily Life Sciences LLC". OpenCorporates . August 3, 2015. Retrieved August 19, 2023.
  3. "NIH Director?s Statement Regarding Dr. Thomas Insel?s Departure - the NIH Director - National Institutes of Health (NIH)". Archived from the original on September 18, 2015. Retrieved September 15, 2015.
  4. Carey, Benedict. "Head of Mental Health Institute Leaving for Google Life Sciences". New York Times .
  5. Brin, Sergey. "Google+ Post".
  6. "Google Life Sciences debuts a new name, Verily". STAT. December 7, 2015. Retrieved December 7, 2015.
  7. "Introducing Verily". YouTube. December 7, 2015. Retrieved December 24, 2017.
  8. Slawski, Bill (March 14, 2016). "Google Assigns 148 Medical Patents to Verily Life Sciences". seobythesea.com. Retrieved September 13, 2016.
  9. Chowdhry, Amit (September 10, 2014). "Google Continues To Build Upon Its Life Sciences Ecosystem". forbes.com. Retrieved September 13, 2014.
  10. Hale, Conor (December 20, 2019). "Johnson & Johnson to take over Verb Surgical, its robotics venture with Verily". FierceBiotech.com. Archived from the original on January 8, 2020. Retrieved January 7, 2020.
  11. Peters, Jay (August 25, 2020). "Verily, Google's health-focused sister company, is getting into insurance". The Verge. Retrieved September 16, 2020.
  12. Alba, Love (September 9, 2022). "Alphabet's Verily Raises $1 Billion and Shakes Up Leadership Team". Bloomberg News .
  13. Scott (January 12, 2023). "New Verily Life Sciences CEO to Cut 15% of Staff, Shake Up C-Suite".
  14. Weise, Karen; Grant, Nico; Isaac, Mike (March 8, 2023). "The Perils of Working on a C.E.O.'s Pet Project". The New York Times. ISSN   0362-4331 . Retrieved March 13, 2023.
  15. Victor, Jon (August 17, 2023). "Alphabet's Verily Moves Toward Spinoff as Revenue Surges" . The Information . Archived from the original on August 17, 2023. Retrieved August 21, 2023.
  16. "Verily Life Sciences". verily.com. Retrieved February 15, 2017.
  17. "Dexcom G7 CGM - Powerfully simple diabetes management". Dexcom. Retrieved June 28, 2023.
  18. "Verily Life Sciences". verily.com. Retrieved February 15, 2017.
  19. Ackerman, Evan (March 3, 2016). "Google and Johnson & Johnson Conjugate to Create Verb Surgical, Promise Fancy Medical Robots". IEEE Spectrum. Retrieved March 3, 2016.
  20. Rushe, Dominic (November 25, 2014). "Google launches 'smart' spoon to help steady shaking hands". The Guardian . Retrieved November 25, 2014.
  21. "Liftware Steady | Liftware". www.liftware.com. Retrieved June 28, 2023.
  22. Kaiser, Jocelyn (July 28, 2014). "Google X sets out to define healthy human | Science/AAAS | News". news.sciencemag.org. Retrieved September 13, 2014.
  23. "Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform - Sep 12, 2016". news.sanofi.us. Retrieved August 16, 2018.
  24. "Verily Life Sciences". verily.com. Retrieved March 8, 2023.
  25. Brian Otis; Babak Parviz (January 16, 2014). "Introducing our smart contact lens project". Google . Retrieved January 17, 2014.
  26. Brian Otis (November 16, 2018). "Update on our Smart Lens program with Alcon". Verily Blog. Retrieved November 21, 2018.
  27. Li, Abner (February 1, 2019). "Verily developing smart shoes for health and weight tracking, fall detection". 9to5Google. Retrieved February 1, 2019.
  28. "Verily and L'Oréal team up on skin research and new digital tools". MobiHealthNews. January 20, 2022. Retrieved January 30, 2022.
  29. Gibbs, Samuel (October 29, 2014). "Google is developing a cancer and heart attack-detecting pill". The Guardian . Retrieved January 20, 2015.
  30. "'Silicon Valley arrogance'? Google misfires as it strives to turn Star Trek technology into reality". June 6, 2016.